Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?
- PMID: 20813960
- PMCID: PMC2947253
- DOI: 10.2353/ajpath.2010.100322
Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?
Abstract
Because inflammation is appreciated as a unifying basis of many widely occurring diseases, the mechanisms involved in its natural resolution are of considerable interest. Using contained, self-limited inflammatory exudates and a systems approach, novel lipid-derived mediators and pathways were uncovered in the resolution of inflammatory exudates. These new families of local mediators control both the duration and magnitude of acute inflammation as well as the return of the site to homeostasis in the process of catabasis. This new genus of specialized proresolving mediators (SPM) includes essential fatty acid-derived lipoxins, resolvins, protectins, and, most recently, maresins. These families were named based on their unique structures and potent stereoselective actions. The temporally initiated biosynthesis of SPM and their direct impact on leukocyte trafficking and macrophage-directed clearance mechanisms provide clear evidence that resolution is an active, programmed response at the tissue level. Moreover, SPM that possess anti-inflammatory (ie, limiting PMN infiltration) and proresolving (enhance macrophage uptake and clearance of apoptotic PMN and microbial particles) actions as well as stimulating mucosal antimicrobial responses demonstrate that anti-inflammation and proresolution are different responses of the host and novel defining properties of these molecules. The mapping of new resolution circuits has opened the possibility for understanding mechanisms that lead from acute to chronic inflammation, or to the resolution thereof, as well as to potential, resolution-based immunopharmacological therapies.
Figures
Similar articles
-
Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.Annu Rev Immunol. 2007;25:101-37. doi: 10.1146/annurev.immunol.25.022106.141647. Annu Rev Immunol. 2007. PMID: 17090225 Review.
-
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.Semin Immunol. 2015 May;27(3):200-15. doi: 10.1016/j.smim.2015.03.004. Epub 2015 Apr 7. Semin Immunol. 2015. PMID: 25857211 Free PMC article. Review.
-
Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.J Intern Med. 2019 Sep;286(3):240-258. doi: 10.1111/joim.12871. Epub 2019 Jan 18. J Intern Med. 2019. PMID: 30565762 Review.
-
Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.J Thromb Haemost. 2009 Jul;7 Suppl 1:44-8. doi: 10.1111/j.1538-7836.2009.03396.x. J Thromb Haemost. 2009. PMID: 19630766 Review.
-
New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.Nat Clin Pract Rheumatol. 2007 Oct;3(10):570-9; quiz 1 p following 589. doi: 10.1038/ncprheum0616. Nat Clin Pract Rheumatol. 2007. PMID: 17906612 Review.
Cited by
-
Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.Free Radic Biol Med. 2012 Jul 1;53(1):160-71. doi: 10.1016/j.freeradbiomed.2012.05.001. Epub 2012 May 8. Free Radic Biol Med. 2012. PMID: 22580336 Free PMC article.
-
Biosynthesis, isolation, and NMR analysis of leukotriene A epoxides: substrate chirality as a determinant of the cis or trans epoxide configuration.J Lipid Res. 2013 Mar;54(3):754-761. doi: 10.1194/jlr.M033746. Epub 2012 Dec 13. J Lipid Res. 2013. PMID: 23242647 Free PMC article.
-
Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms.FASEB J. 2022 Nov;36(11):e22579. doi: 10.1096/fj.202201114R. FASEB J. 2022. PMID: 36183323 Free PMC article.
-
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial Cells.Pharmaceuticals (Basel). 2024 Aug 14;17(8):1066. doi: 10.3390/ph17081066. Pharmaceuticals (Basel). 2024. PMID: 39204170 Free PMC article.
-
[Systemic inflammation].Internist (Berl). 2013 Apr;54(4):397-8. doi: 10.1007/s00108-012-3135-1. Internist (Berl). 2013. PMID: 23503718 German. No abstract available.
References
-
- Cotran RS, Kumar V, Collins T. In: Robbins Pathologic Basis of Disease. Cotran RS, Kumar V, Collins T, editors. W.B. Saunders Co.; Philadelphia: 1999.
-
- Malech HL, Nauseef WM. Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol. 1997;34:279–290. - PubMed
-
- Henson PM. Resolution of inflammation. Chest. 1991;99:2S–6S. - PubMed
-
- Winyard PG, Willoughby DA. In: Inflammation Protocols. Winyard PG, Willoughby DA, editors. Humana; Totowa NJ: 2003.
-
- Russell DG, Gordon S. In: Phagocyte-Pathogen Interactions: Macrophages and the Host Response to Infection. Russell DG, Gordon S, editors. ASM Press; Washington: 2009.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources